Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cairo University
Asthmatic patients are recruited and divided into two groups. One receives Alfacalcidol beside their normal medications while the other acts as a control group receiving the normal asthma medication.
Both groups are followed up for four months.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. Patients diagnosed with asthma
2. Non-smokers
You may not be if
1. Liver impairment
2. Kidney impairment
3. Patients receiving digoxin
4. Known hypersensitivity to 1α-hydroxyvitamin D3, vitamin D or any of its analogues and derivatives
5. Hypercalcaemia
6. Hyperphosphatemia
7. Pregnancy and breast-feeding
8. Patients on nutritional supplements with a potential effect on 25(OH)D serum concentrations
9. Had a History of stones in the urinary tract or diseases of calcium or bone metabolism
Clareo Health | The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients
